Title | Type | ![]() |
H index | Total Docs. (2021) | Total Docs. (3years) | Total Refs. (2021) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2021) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Neuropharmacology | journal | 1.722 Q1 | 82 | 145 | 278 | 16406 | 2427 | 258 | 7.24 | 113.14 | ![]() |
2 | Recent Patents on Inflammation and Allergy Drug Discovery | journal | 0.879 Q1 | 29 | 0 | 47 | 0 | 282 | 45 | 5.90 | 0.00 | ![]() |
3 | Current Medicinal Chemistry | journal | 0.800 Q2 | 183 | 400 | 1146 | 53423 | 5112 | 1047 | 4.03 | 133.56 | ![]() |
4 | Current Cancer Drug Targets | journal | 0.732 Q2 | 96 | 72 | 243 | 6250 | 859 | 231 | 2.76 | 86.81 | ![]() |
5 | Current Molecular Pharmacology | journal | 0.729 Q2 | 42 | 106 | 94 | 8305 | 354 | 90 | 3.87 | 78.35 | ![]() |
6 | Current Vascular Pharmacology | journal | 0.670 Q2 | 63 | 60 | 233 | 4605 | 628 | 196 | 3.12 | 76.75 | ![]() |
7 | Current Gene Therapy | journal | 0.656 Q2 | 75 | 40 | 123 | 3005 | 476 | 107 | 4.13 | 75.13 | ![]() |
8 | Current Drug Targets | journal | 0.654 Q2 | 107 | 140 | 450 | 12048 | 1519 | 430 | 2.84 | 86.06 | ![]() |
9 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.629 Q2 | 46 | 42 | 88 | 3536 | 321 | 85 | 2.80 | 84.19 | ![]() |
10 | Current Topics in Medicinal Chemistry | journal | 0.628 Q2 | 122 | 209 | 713 | 13521 | 2210 | 582 | 2.80 | 64.69 | ![]() |
11 | Current Radiopharmaceuticals | journal | 0.587 Q2 | 26 | 42 | 88 | 1833 | 292 | 78 | 2.47 | 43.64 | ![]() |
12 | Current Pharmaceutical Design![]() | journal | 0.571 Q2 | 166 | 434 | 1532 | 41393 | 4939 | 1411 | 2.94 | 95.38 | ![]() |
13 | CNS and Neurological Disorders - Drug Targets | journal | 0.561 Q3 | 90 | 77 | 227 | 8044 | 722 | 213 | 2.71 | 104.47 | ![]() |
14 | Current Reviews in Clinical and Experimental Pharmacology | journal | 0.536 Q2 | 43 | 44 | 85 | 1993 | 254 | 79 | 2.36 | 45.30 | ![]() |
15 | Mini-Reviews in Medicinal Chemistry | journal | 0.512 Q3 | 95 | 180 | 393 | 18533 | 1440 | 386 | 3.48 | 102.96 | ![]() |
16 | Current Drug Delivery | journal | 0.460 Q2 | 65 | 132 | 299 | 7550 | 920 | 287 | 3.46 | 57.20 | ![]() |
17 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.409 Q3 | 40 | 21 | 58 | 1266 | 122 | 50 | 2.24 | 60.29 | ![]() |
18 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.403 Q3 | 100 | 206 | 647 | 13581 | 1601 | 632 | 2.23 | 65.93 | ![]() |
19 | Reviews on Recent Clinical Trials | journal | 0.386 Q3 | 32 | 56 | 131 | 1863 | 205 | 111 | 1.43 | 33.27 | ![]() |
20 | Drug Metabolism Letters | journal | 0.357 Q2 | 28 | 24 | 34 | 1151 | 62 | 29 | 1.64 | 47.96 | ![]() |
21 | Current Drug Safety | journal | 0.333 Q3 | 37 | 36 | 121 | 2372 | 242 | 118 | 1.22 | 65.89 | ![]() |
22 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.323 Q3 | 24 | 41 | 58 | 1832 | 119 | 53 | 2.07 | 44.68 | ![]() |
23 | Medicinal Chemistry | journal | 0.323 Q3 | 46 | 96 | 254 | 4745 | 523 | 247 | 2.01 | 49.43 | ![]() |
24 | Recent Patents on Drug Delivery and Formulation | journal | 0.323 Q3 | 36 | 0 | 69 | 0 | 139 | 63 | 1.60 | 0.00 | ![]() |
25 | Infectious Disorders - Drug Targets | journal | 0.319 Q3 | 55 | 151 | 210 | 5066 | 312 | 200 | 1.30 | 33.55 | ![]() |
26 | Open Medicinal Chemistry Journal![]() | journal | 0.319 Q3 | 18 | 3 | 30 | 159 | 59 | 27 | 1.61 | 53.00 | ![]() |
27 | Current Nanoscience | journal | 0.310 Q3 | 47 | 76 | 224 | 6153 | 364 | 217 | 1.52 | 80.96 | ![]() |
28 | Current Drug Discovery Technologies | journal | 0.301 Q4 | 44 | 74 | 152 | 4631 | 266 | 148 | 1.55 | 62.58 | ![]() |
29 | Recent Advances in Anti-Infective Drug Discovery | journal | 0.301 Q4 | 33 | 21 | 44 | 909 | 85 | 38 | 1.50 | 43.29 | ![]() |
30 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.300 Q3 | 42 | 38 | 99 | 1338 | 146 | 94 | 1.07 | 35.21 | ![]() |
31 | Current Computer-Aided Drug Design | journal | 0.258 Q4 | 31 | 82 | 151 | 3104 | 214 | 142 | 1.55 | 37.85 | ![]() |
32 | Combinatorial Chemistry and High Throughput Screening | journal | 0.244 Q4 | 66 | 168 | 286 | 7746 | 391 | 262 | 1.39 | 46.11 | ![]() |
33 | Letters in Drug Design and Discovery | journal | 0.213 Q3 | 35 | 96 | 420 | 4819 | 475 | 396 | 1.02 | 50.20 | ![]() |
34 | Current Bioactive Compounds | journal | 0.211 Q3 | 27 | 79 | 256 | 4876 | 272 | 249 | 1.04 | 61.72 | ![]() |
35 | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry | journal | 0.207 Q4 | 14 | 0 | 10 | 0 | 16 | 9 | 0.00 | 0.00 | ![]() |
36 | Current Pharmaceutical Analysis | journal | 0.177 Q3 | 25 | 114 | 308 | 4809 | 193 | 303 | 0.59 | 42.18 | ![]() |
37 | Current Drug Therapy | journal | 0.175 Q3 | 17 | 40 | 88 | 1989 | 68 | 86 | 0.80 | 49.73 | ![]() |
38 | Anti-Infective Agents | journal | 0.160 Q4 | 24 | 61 | 84 | 2602 | 59 | 81 | 0.77 | 42.66 | ![]() |
39 | Current Enzyme Inhibition | journal | 0.157 Q4 | 18 | 25 | 64 | 1184 | 41 | 58 | 0.70 | 47.36 | ![]() |
40 | Current Pharmacogenomics and Personalized Medicine | journal | 0.139 Q4 | 19 | 13 | 45 | 707 | 23 | 39 | 0.25 | 54.38 | ![]() |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2022. Data Source: Scopus®